nach oben

Cardiovascular Toxicology

Erschienen in:

25.02.2019

SSeCKS/Gravin/AKAP12 Inhibits PKCζ-Mediated Reduction of ERK5 Transactivation to Prevent Endotoxin-Induced Vascular dysfunction

verfasst von: Zilin Li, Jing Hu, Jian Guo, Li Fan, Shaowei Wang, Ning Dou, Jian Zuo, Shiqiang Yu

Erschienen in: Cardiovascular Toxicology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

SSeCKS/Gravin/AKAP12 is a protein kinase C (PKC) substrate that inhibits the activity of PKC through binding with it. SSeCKS is expressed in vascular endothelial cells (ECs). The atypical PKC isoform ζ (PKCζ) is a pathologic mediator of endothelial dysfunction. However, the functional significance of SSeCKS/PKCζ dimerization in the vascular endothelium remains poorly understood. Given this background, we investigated the effects of SSeCKS on endothelial dysfunction and elucidated the possible mechanism involved. Vascular endothelial dysfunction and inflammatory changes were induced by treatment with bacterial endotoxin lipopolysaccharide (LPS, a vascular endothelial toxicity inducer). LPS can increase the level of SSeCKS. However, we also found that depletion of SSeCKS aggravated the LPS-induced vascular endothelial dysfunction, upregulated pro-inflammatory proteins and phosphorylation level of PKCζ, increased ROS formation, decreased extracellular-signal-regulated kinase 5 (ERK5) transcriptional activity, and reduced eNOS expression. Further examination revealed that depletion of SSeCKS increased PKCζ/ERK5 dimerization. These findings provide preliminary evidence that the expression of SSeCKS induced by LPS, as a negative feedback mechanism, has the potential to improve endothelium-dependent relaxation in vascular disease conditions by inhibiting PKCζ-mediated reduction of ERK5 transactivation.

Nur mit Berechtigung zugänglich

Lin, X., Nelson, P., & Gelman, I. H. (2000). SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. Molecular and Cellular Biology, 20, 7259–7272.CrossRefPubMedPubMedCentral

Guo, L. W., Gao, L., Rothschild, J., Su, B., & Gelman, I. H. (2011). Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12. Journal of Biological Chemistry, 286, 38356–38366.CrossRefPubMed

Weissmuller, T., Glover, L. E., Fennimore, B., Curtis, V. F., MacManus, C. F., Ehrentraut, S. F., et al. (2014). HIF-dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function. FASEB Journal, 28, 256–264.CrossRefPubMedPubMedCentral

Yan, M., Zhao, J., Zhu, S., Shao, X., Zhang, L., Gao, H., et al. (2014). Expression of SRC suppressed C kinase substrate in rat neural tissues during inflammation. Neurochemical Research, 39, 748–757.CrossRefPubMed

Cheng, C., Liu, H., Ge, H., Qian, J., Qin, J., Sun, L., et al. (2007). Lipopolysaccharide induces expression of SSeCKS in rat lung microvascular endothelial cell. Molecular and Cellular Biochemistry, 305, 1–8.CrossRefPubMed

Yang, Z., Breider, M. A., Carroll, R. C., Miller, M. S., & Bochsler, P. N. (1996). Soluble CD14 and lipopolysaccharide-binding protein from bovine serum enable bacterial lipopolysaccharide-mediated cytotoxicity and activation of bovine vascular endothelial cells in vitro. Journal of Leukocyte Biology, 59, 241–247.CrossRefPubMed

Akakura, S., Nochajski, P., Gao, L., Sotomayor, P., Matsui, S., & Gelman, I. H. (2010). Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12. Cell Cycle, 9, 4656–4665.CrossRefPubMedPubMedCentral

Song, H. B., Jun, H. O., Kim, J. H., Yu, Y. S., Kim, K. W., & Kim, J. H. (2014). Suppression of protein kinase C-zeta attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy. Biochemical and Biophysical Research Communications, 444, 63–68.CrossRefPubMed

Li, Z. L., Liu, J. C., Liu, S. B., Li, X. Q., Yi, D. H., & Zhao, M. G. (2012). Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus. PLoS ONE, 7, e38787.CrossRefPubMedPubMedCentral

10.

Hecquet, C. M., Ahmmed, G. U., & Malik, A. B. (2010). TRPM2 channel regulates endothelial barrier function. Advances in Experimental Medicine and Biology, 661, 155–167.CrossRefPubMed

11.

Sturza, A., Leisegang, M. S., Babelova, A., Schroder, K., Benkhoff, S., Loot, A. E., et al. (2013). Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta. Hypertension, 62, 140–146.CrossRefPubMed

12.

Lund, D. D., Brooks, R. M., Faraci, F. M., & Heistad, D. D. (2007). Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice. American Journal of Physiology Heart Circulatory Physiology, 293, H3726–H3731.CrossRefPubMed

13.

Witzenbichler, B., Westermann, D., Knueppel, S., Schultheiss, H. P., & Tschope, C. (2005). Protective role of angiopoietin-1 in endotoxic shock. Circulation, 111, 97–105.CrossRefPubMed

14.

Lu, J. L., Schmiege, L. M. 3rd, Kuo, L., & Liao, J. C. (1996). Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochemical and Biophysical Research Communications, 225, 1–5.CrossRefPubMed

15.

Yazji, I., Sodhi, C. P., Lee, E. K., Good, M., Egan, C. E., Afrazi, A., et al. (2013). Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling. Proceedings of the National Academy of Sciences USA, 110, 9451–9456.CrossRef

16.

Jonigk, D., Al-Omari, M., Maegel, L., Muller, M., Izykowski, N., Hong, J., et al. (2013). Anti-inflammatory and immunomodulatory properties of alpha1-antitrypsin without inhibition of elastase. Proceedings of the National Academy of Sciences USA, 110, 15007–15012.CrossRef

17.

Westerterp, M., Berbee, J. F., Pires, N. M., van Mierlo, G. J., Kleemann, R., Romijn, J. A., et al. (2007). Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation, 116, 2173–2181.CrossRefPubMed

18.

Liang, C. F., Liu, J. T., Wang, Y., Xu, A., & Vanhoutte, P. M. (2013). Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arteriosclerosis Thrombosis and Vascular Biology, 33, 777–784.CrossRef

19.

Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420, 868–874.CrossRefPubMed

20.

Park, J. H., Jeong, Y. J., Won, H. K., Choi, S. Y., Park, J. H., & Oh, S. M. (2014). Activation of TOPK by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NF-kappaB activity in leukemia cells. Cellular Signalling, 26, 849–856.CrossRefPubMed

21.

Capiralla, H., Vingtdeux, V., Venkatesh, J., Dreses-Werringloer, U., Zhao, H., Davies, P., et al. (2012). Identification of potent small-molecule inhibitors of STAT3 with anti-inflammatory properties in RAW 264.7 macrophages. FEBS Journal, 279, 3791–3799.CrossRefPubMed

22.

Nigro, P., Abe, J., Woo, C. H., Satoh, K., McClain, C., O’Dell, M. R., et al. (2010). PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5. Blood, 116, 1971–1979.CrossRefPubMedPubMedCentral

23.

Nithianandarajah-Jones, G. N., Wilm, B., Goldring, C. E., Muller, J., & Cross, M. J. (2012). ERK5: structure, regulation and function. Cellular Signalling, 24, 2187–2196.CrossRefPubMed

24.

Dong, F., Gutkind, J. S., & Larner, A. C. (2001). Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C. Regulation of cell proliferation and survival. Journal of Biological Chemistry, 276, 10811–10816.CrossRefPubMed

25.

Sohn, S. J., Sarvis, B. K., Cado, D., & Winoto, A. (2002). ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. Journal of Biological Chemistry, 277, 43344–43351.CrossRefPubMed

26.

Regan, C. P., Li, W., Boucher, D. M., Spatz, S., Su, M. S., & Kuida, K. (2002). Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proceedings of the National Academy of Sciences USA, 99, 9248–9253.CrossRef

27.

Parmar, K. M., Larman, H. B., Dai, G., Zhang, Y., Wang, E. T., Moorthy, S. N., et al. (2006). Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. Journal of Clinical Investigation, 116, 49–58.CrossRefPubMed

28.

Dekker, R. J., van Soest, S., Fontijn, R. D., Salamanca, S., de Groot, P. G., VanBavel, E., et al. (2002). Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood, 100, 1689–1698.CrossRefPubMed

29.

SenBanerjee, S., Lin, Z., Atkins, G. B., Greif, D. M., Rao, R. M., Kumar, A., et al. (2004). KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. Journal of Experimental Medicine, 199, 1305–1315.CrossRefPubMed

30.

Wu, K., Tian, S., Zhou, H., & Wu, Y. (2013). Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation. Biochemical Pharmacology, 85, 1753–1760.CrossRefPubMed

31.

Chen, L., Liu, J. C., Zhang, X. N., Guo, Y. Y., Xu, Z. H., Cao, W., et al. (2008). Down-regulation of NR2B receptors partially contributes to analgesic effects of Gentiopicroside in persistent inflammatory pain. Neuropharmacology, 54, 1175–1181.CrossRefPubMed

32.

Reinhart-King, C. A., Fujiwara, K., & Berk, B. C. (2008). Physiologic stress-mediated signaling in the endothelium. Methods in Enzymology, 443, 25–44.CrossRefPubMed

33.

Bagi, Z., Frangos, J. A., Yeh, J. C., White, C. R., Kaley, G., & Koller, A. (2005). PECAM-1 mediates NO-dependent dilation of arterioles to high temporal gradients of shear stress. Arteriosclerosis Thrombosis and Vascular Biology, 25, 1590–1595.CrossRef

34.

Kumagai, R., Lu, X., & Kassab, G. S. (2009). Role of glycocalyx in flow-induced production of nitric oxide and reactive oxygen species. Free Radical Biology and Medicine, 47, 600–607.CrossRefPubMed

35.

Hou, S., Ding, H., Lv, Q., Yin, X., Song, J., Landen, N. X., et al. (2014). Therapeutic effect of intravenous infusion of perfluorocarbon emulsion on LPS-induced acute lung injury in rats. PLoS ONE, 9, e87826.CrossRefPubMedPubMedCentral

36.

Yang, N., Liu, Y. Y., Pan, C. S., Sun, K., Wei, X. H., Mao, X. W., et al. (2014). Pre-treatment with andrographolide pills attenuates lipopolysaccharide-induced pulmonary microcirculatory disturbance and acute lung injury in rats. Microcirculation, 21, 703–716CrossRef

37.

Lee, K. S., Kim, J., Kwak, S. N., Lee, K. S., Lee, D. K., Ha, K. S., et al. (2014). Functional role of NF-kappaB in expression of human endothelial nitric oxide synthase. Biochemical and Biophysical Research Communications, 448, 101–107.CrossRefPubMed

38.

Woo, C. H., Shishido, T., McClain, C., Lim, J. H., Li, J. D., Yang, J., et al. (2008). Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Circulation Research, 102, 538–545.CrossRefPubMed

39.

Surapisitchat, J., Hoefen, R. J., Pi, X., Yoshizumi, M., Yan, C., & Berk, B. C. (2001). Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members. Proceedings of the National Academy of Sciences USA, 98, 6476–6481.CrossRef

40.

Collins, A. R., Meehan, W. P., Kintscher, U., Jackson, S., Wakino, S., Noh, G., et al. (2001). Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arteriosclerosis Thrombosis and Vascular Biology, 21, 365–371.CrossRef

41.

Akaike, M., Che, W., Marmarosh, N. L., Ohta, S., Osawa, M., Ding, B., et al. (2004). The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells. Molecular and Cellular Biology, 24, 8691–8704.CrossRefPubMedPubMedCentral

42.

Leverence, J. T., Medhora, M., Konduri, G. G., & Sampath, V. (2011). Lipopolysaccharide-induced cytokine expression in alveolar epithelial cells: role of PKCzeta-mediated p47phox phosphorylation. Chemico Biological Interactions, 189, 72–81.CrossRefPubMed

Titel: SSeCKS/Gravin/AKAP12 Inhibits PKCζ-Mediated Reduction of ERK5 Transactivation to Prevent Endotoxin-Induced Vascular dysfunction
verfasst von: Zilin Li
Jing Hu
Jian Guo
Li Fan
Shaowei Wang
Ning Dou
Jian Zuo
Shiqiang Yu
Publikationsdatum: 25.02.2019
Verlag: Springer US
Erschienen in: Cardiovascular Toxicology / Ausgabe 4/2019
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-018-09502-9

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts

Carnitine Supplementation Attenuates Sunitinib-Induced Inhibition of AMP-Activated Protein Kinase Downstream Signals in Cardiac Tissues

Diagnostic Value of Parameters Related to White Blood Cell Counts for Troponin I Elevation in CO Poisoning

Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib

Effect of Gestational Age on Maternofetal Vascular Function Following Single Maternal Engineered Nanoparticle Exposure

Micheliolide Protects Against Doxorubicin-Induced Cardiotoxicity in Mice by Regulating PI3K/Akt/NF-kB Signaling Pathway